{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:31:32Z","timestamp":1794591092104,"version":"4.9.1"},"reference-count":197,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cardiac magnetic resonance (CMR) plays an established role in the assessment of cardiac patients. In this document, the aim is to demonstrate and clarify the role of CMR in the clinical management of heart disease for general cardiologists in everyday clinical practice. This document will cover the clinical indications, prognostic values, and limitations of CMR in the diagnosis and follow-up of heart disease, including ischaemic heart disease, heart failure, cardiomyopathies, valvular heart disease, aortopathies, cardiac masses, pericardial conditions, and adult congenital heart disease. This document also provides a basic understanding of the use of different CMR sequences and how cardiac function is assessed. With the increasing number of patients with cardiac implantable electronic devices, a brief understanding and advice on the use of CMR in this growing patient population who may need a scan during their lifetime is discussed. This document outlines the clinical applications of CMR and its use in everyday clinical practice for cardiologists who are not experts in CMR.<\/jats:p>","DOI":"10.1093\/eurheartj\/ehag678","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:02:35Z","timestamp":1790773355000},"source":"Crossref","is-referenced-by-count":0,"title":["Implementation of cardiac magnetic resonance imaging in everyday cardiology practice"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8007-0476","authenticated-orcid":false,"given":"Sarah","family":"Moharem-Elgamal","sequence":"first","affiliation":[{"name":"Cardiology Department, Liverpool Heart and Chest Hospital and Liverpool Centre for Cardiovascular Science at University of Liverpool , Liverpool L14 3PE ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6900-6705","authenticated-orcid":false,"given":"Anna","family":"Baritussio","sequence":"additional","affiliation":[{"name":"Cardiology, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Padua University Hospital , Padua ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxandra","family":"Christodorescu","sequence":"additional","affiliation":[{"name":"Department V Internal Medicine, University of Medicine and Pharmacy V. Babes Timisoara, Institute of Cardiology Research Center , Timi\u0219oara ,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2595-2433","authenticated-orcid":false,"given":"Marc","family":"Ferrini","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Vascular Pathology, CH Saint Joseph and Saint Luc , Lyon ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Benfari","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cardio-Thoracic Department, University Hospital of Verona , Verona ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Ricci","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Imaging and Clinical Sciences, G.d'Annunzio University of Chieti-Pescara , Chieti ,","place":["Italy"]},{"name":"Heart Department, SS. Annunziata Hospital , Chieti ,","place":["Italy"]},{"name":"Department of Clinical Sciences, Lund University , Malm\u00f6 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipa","family":"Xavier Valente","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital Universitario Vall d'Hebron, Institut de Recerca (VHIR), Universitat Aut\u00f2noma de Barcelona , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 F","family":"Rodr\u00edguez Palomares","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital Universitario Vall d'Hebron, Institut de Recerca (VHIR), Universitat Aut\u00f2noma de Barcelona , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Pontone","sequence":"additional","affiliation":[{"name":"Department of Perioperative Cardiology and Cardiovascular Imaging, Centro Cardiologico Monzino IRCCS , Milan ,","place":["Italy"]},{"name":"Department of Biomedical, Surgical and Dental Sciences, University of Milan , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4723-6646","authenticated-orcid":false,"given":"Stefano","family":"Nistri","sequence":"additional","affiliation":[{"name":"Department of Cardiology, CMSR , Vicenza ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"2026111312060303200_ehag678-B1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1532-429X-15-9","article-title":"European cardiovascular magnetic resonance (EuroCMR) registry \u2013 multi national results from 57 centers in 15 countries","volume":"15","author":"Bruder","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026111312060303200_ehag678-B2","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/01.rct.0000238010.64931.c6","article-title":"Cardiac magnetic resonance imaging using an open 0.35 T system","volume":"31","author":"Klein","year":"2007","journal-title":"J Comput Assist Tomogr"},{"key":"2026111312060303200_ehag678-B3","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1093\/eurheartj\/ehac035","article-title":"Improving cardiovascular magnetic resonance access in low- and middle-income countries for cardiomyopathy assessment: rapid cardiovascular magnetic resonance","volume":"43","author":"Menacho","year":"2022","journal-title":"Eur Heart J"},{"key":"2026111312060303200_ehag678-B4"},{"key":"2026111312060303200_ehag678-B5","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jcmg.2016.12.025","article-title":"MRI-Derived Myocardial strain measures in normal subjects","volume":"11","author":"Vo","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B6","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jcmg.2024.07.011","article-title":"Myocardial strain imaging: theory, current practice, and the future","volume":"18","author":"Smiseth","year":"2025","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B7","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jcmg.2023.05.019","article-title":"Myocardial strain measurements derived from MR feature-tracking: influence of sex, age, field strength, and vendor","volume":"17","author":"Yang","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1148\/radiol.210545","article-title":"Allergic-like hypersensitivity reactions to gadolinium-based contrast agents: an 8-year cohort study of 154 539 patients","volume":"303","author":"Ahn","year":"2022","journal-title":"Radiology"},{"key":"2026111312060303200_ehag678-B9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1001\/jamainternmed.2019.5284","article-title":"Risk of nephrogenic systemic fibrosis in patients with stage 4 or 5 chronic kidney disease receiving a group II gadolinium-based contrast agent: a systematic review and meta-analysis","volume":"180","author":"Woolen","year":"2020","journal-title":"JAMA Intern Med"},{"key":"2026111312060303200_ehag678-B10","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1136\/hrt.2007.125039","article-title":"Contraindications to magnetic resonance imaging: non-invasive imaging","volume":"94","author":"Dill","year":"2008","journal-title":"Heart"},{"key":"2026111312060303200_ehag678-B11","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.251794","article-title":"Nephrogenic systemic fibrosis in patients with advanced renal dysfunction following gadolinium-based contrast agents","volume":"317","author":"Mallepally","year":"2025","journal-title":"Radiology"},{"key":"2026111312060303200_ehag678-B12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1148\/radiol.2020202903","article-title":"Use of intravenous gadolinium-based contrast Media in patients with kidney disease: consensus statements from the American college of radiology and the National Kidney Foundation","volume":"298","author":"Weinreb","year":"2021","journal-title":"Radiology"},{"key":"2026111312060303200_ehag678-B13","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.jacc.2007.04.053","article-title":"Quantitative magnetic resonance perfusion imaging detects anatomic and physiologic coronary artery disease as measured by coronary angiography and fractional flow reserve","volume":"50","author":"Costa","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026111312060303200_ehag678-B14","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"2026111312060303200_ehag678-B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cjca.2023.09.020","article-title":"The Canadian cardiovascular society classification of acute atherothrombotic myocardial infarction based on stages of tissue injury severity: an expert consensus statement","volume":"40","author":"Kumar","year":"2024","journal-title":"Can J Cardiol"},{"key":"2026111312060303200_ehag678-B16","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ahj.2008.04.012","article-title":"The use of periinfarct contrast-enhanced cardiac magnetic resonance imaging for the prediction of late postmyocardial infarction ventricular dysfunction","volume":"156","author":"Rubenstein","year":"2008","journal-title":"Am Heart J"},{"key":"2026111312060303200_ehag678-B17","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1161\/CIRCIMAGING.113.000702","article-title":"Value of early cardiovascular magnetic resonance for the prediction of adverse arrhythmic cardiac events after a first noncomplicated ST-segment-elevation myocardial infarction","volume":"6","author":"Izquierdo","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B18","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.jacc.2014.06.1194","article-title":"Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction","volume":"64","author":"Eitel","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026111312060303200_ehag678-B19","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.jcmg.2014.05.010","article-title":"Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients","volume":"7","author":"van Kranenburg","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B20","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1016\/j.jacc.2010.02.033","article-title":"Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magnetic resonance","volume":"55","author":"Larose","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026111312060303200_ehag678-B21","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1136\/hrt.2007.122622","article-title":"Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study","volume":"94","author":"Wu","year":"2008","journal-title":"Heart"},{"key":"2026111312060303200_ehag678-B22","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/1745-6215-15-249","article-title":"Prognosis after ST-elevation myocardial infarction: a study on cardiac magnetic resonance imaging versus clinical routine","volume":"15","author":"de Waha","year":"2014","journal-title":"Trials"},{"key":"2026111312060303200_ehag678-B23","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1056\/NEJM200011163432003","article-title":"The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction","volume":"343","author":"Kim","year":"2000","journal-title":"N Engl J Med"},{"key":"2026111312060303200_ehag678-B24","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1148\/radiol.2017161898","article-title":"Incidence, outcomes, and predictors of ventricular thrombus after reperfused ST-segment-elevation myocardial infarction by using sequential cardiac MR imaging","volume":"284","author":"Cambronero-Cortinas","year":"2017","journal-title":"Radiology"},{"key":"2026111312060303200_ehag678-B25","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1016\/j.jacc.2006.05.078","article-title":"Contrast-enhanced cardiovascular magnetic resonance imaging of right ventricular infarction","volume":"48","author":"Kumar","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026111312060303200_ehag678-B26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1177\/2048872617719650","article-title":"Comparison of distinctive clinical and cardiac magnetic resonance features between ST elevation myocardial infarction patients with incomplete myocardial rupture and those with moderate to severe pericardial effusion","volume":"8","author":"Pineda","year":"2019","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026111312060303200_ehag678-B27","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1136\/hrt.2004.039768","article-title":"Cardiovascular magnetic resonance of left ventricular pseudoaneurysm","volume":"91","author":"Varghese","year":"2005","journal-title":"Heart"},{"key":"2026111312060303200_ehag678-B28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1148\/radiol.2361031699","article-title":"True versus false left ventricular aneurysm: differentiation with MR imaging\u2013initial experience","volume":"236","author":"Konen","year":"2005","journal-title":"Radiology"},{"key":"2026111312060303200_ehag678-B29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1365-2796.2012.02591.x","article-title":"Assessing patients with myocardial infarction and nonobstructed coronary arteries (MINOCA)","volume":"273","author":"Beltrame","year":"2013","journal-title":"J Intern Med"},{"key":"2026111312060303200_ehag678-B30","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"42","author":"Collet","year":"2021","journal-title":"Eur Heart J"},{"key":"2026111312060303200_ehag678-B31","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1093\/eurheartj\/ehz332","article-title":"Clinical use of intracoronary imaging. Part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions","volume":"40","author":"Johnson","year":"2019","journal-title":"Eur Heart J"},{"key":"2026111312060303200_ehag678-B32","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/ehjacc\/zuab049","article-title":"Diagnostic pathways in myocardial infarction with non-obstructive coronary artery disease (MINOCA)","volume":"10","author":"Occhipinti","year":"2021","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026111312060303200_ehag678-B33","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf784.2159","article-title":"How late is too late? Influence of CMR timing in suspected MINOCA","volume":"46","author":"Bisaccia","year":"2025","journal-title":"Eur Heart J"},{"key":"2026111312060303200_ehag678-B34","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/j.jcmg.2021.03.024","article-title":"Refining the role of CMR imaging in MINOCA","volume":"14","author":"Pasupathy","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B35","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.jcmg.2021.02.021","article-title":"Early comprehensive cardiovascular magnetic resonance imaging in patients with myocardial infarction with nonobstructive coronary arteries","volume":"14","author":"S\u00f6rensson","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B36","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.jcmg.2016.11.010","article-title":"Myocardial infarction with nonobstructed coronary arteries: impact of CMR early after presentation","volume":"10","author":"Dastidar","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B37","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1136\/heartjnl-2019-316295","article-title":"Early cardiac magnetic resonance imaging in troponin-positive acute chest pain and non-obstructed coronary arteries","volume":"106","author":"V\u00e1g\u00f3","year":"2020","journal-title":"Heart"},{"key":"2026111312060303200_ehag678-B38","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/j.jcmg.2018.12.023","article-title":"Prognostic role of CMR and conventional risk factors in myocardial infarction with nonobstructed coronary arteries","volume":"12","author":"Dastidar","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B39","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1016\/j.mayocp.2020.11.026","article-title":"Prognostic value of cardiac magnetic resonance imaging in acute coronary syndrome patients with troponin elevation and nonobstructive coronary arteries","volume":"96","author":"Luis","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"2026111312060303200_ehag678-B40","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"key":"2026111312060303200_ehag678-B41","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1093\/ehjci\/jeab244","article-title":"Non-invasive imaging in coronary syndromes: recommendations of the European Association of Cardiovascular Imaging and the American Society of Echocardiography, in collaboration with the American Society of Nuclear Cardiology, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance","volume":"23","author":"Edvardsen","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12968-020-00610-6","article-title":"Standardized image interpretation and post-processing in cardiovascular magnetic resonance - 2020 update: Society for Cardiovascular Magnetic Resonance (SCMR): board of trustees task force on standardized post-processing","volume":"22","author":"Schulz-Menger","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026111312060303200_ehag678-B43","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/j.jacc.2021.08.022","article-title":"Stress cardiac magnetic resonance myocardial perfusion imaging: JACC review topic of the week","volume":"78","author":"Patel","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026111312060303200_ehag678-B44","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1056\/NEJMoa1716734","article-title":"Magnetic resonance perfusion or fractional flow reserve in coronary disease","volume":"380","author":"Nagel","year":"2019","journal-title":"N Engl J Med"},{"key":"2026111312060303200_ehag678-B45","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1001\/jamacardio.2023.1290","article-title":"Diagnostic and prognostic value of stress cardiovascular magnetic resonance imaging in patients with known or suspected coronary artery disease: a systematic review and meta-analysis","volume":"8","author":"Ricci","year":"2023","journal-title":"JAMA Cardiol"},{"key":"2026111312060303200_ehag678-B46","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12968-020-00607-1","article-title":"Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update","volume":"22","author":"Kramer","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026111312060303200_ehag678-B47","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1016\/j.jcmg.2020.06.041","article-title":"Assessment of multivessel coronary artery disease using cardiovascular magnetic resonance pixelwise quantitative perfusion mapping","volume":"13","author":"Kotecha","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B48","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12968-018-0435-1","article-title":"Quantitative cardiovascular magnetic resonance perfusion imaging identifies reduced flow reserve in microvascular coronary artery disease","volume":"20","author":"Zorach","year":"2018","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026111312060303200_ehag678-B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12968-016-0318-2","article-title":"Splenic T1-mapping: a novel quantitative method for assessing adenosine stress adequacy for cardiovascular magnetic resonance","volume":"19","author":"Liu","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026111312060303200_ehag678-B50","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/ehjci\/jeaa252","article-title":"Quantitative cardiovascular magnetic resonance myocardial perfusion mapping to assess hyperaemic response to adenosine stress","volume":"22","author":"Kotecha","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B51","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/ehjci\/jeaa268","article-title":"Stressed enough? Hyperaemic thresholds during quantitative cardiovascular magnetic resonance perfusion mapping","volume":"22","author":"Farzaneh-Far","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B52","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1161\/01.CIR.0000142045.22628.74","article-title":"Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization","volume":"110","author":"Selvanayagam","year":"2004","journal-title":"Circulation"},{"key":"2026111312060303200_ehag678-B53","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0140-6736(11)61335-4","article-title":"Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial","volume":"379","author":"Greenwood","year":"2012","journal-title":"Lancet"},{"key":"2026111312060303200_ehag678-B54","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/eurheartj\/ehs022","article-title":"MR-IMPACT II: magnetic resonance imaging for myocardial perfusion assessment in coronary artery disease trial: perfusion-cardiac magnetic resonance vs. Single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial","volume":"34","author":"Schwitter","year":"2013","journal-title":"Eur Heart J"},{"key":"2026111312060303200_ehag678-B55","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1001\/jama.2016.12680","article-title":"Effect of care guided by cardiovascular magnetic resonance, myocardial perfusion scintigraphy, or NICE guidelines on subsequent unnecessary angiography rates: the CE-MARC 2 randomized clinical trial","volume":"316","author":"Greenwood","year":"2016","journal-title":"JAMA"},{"key":"2026111312060303200_ehag678-B56","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1093\/eurheartj\/ehac286","article-title":"Functional stress imaging to predict abnormal coronary fractional flow reserve: the PACIFIC 2 study","volume":"43","author":"Driessen","year":"2022","journal-title":"Eur Heart J"},{"key":"2026111312060303200_ehag678-B57","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s40336-014-0070-2","article-title":"The role of PET quantification in cardiovascular imaging","volume":"2","author":"Slomka","year":"2014","journal-title":"Clin Transl Imaging"},{"key":"2026111312060303200_ehag678-B58","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1161\/01.CIR.99.6.763","article-title":"Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography","volume":"99","author":"Nagel","year":"1999","journal-title":"Circulation"},{"key":"2026111312060303200_ehag678-B59","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10153279","article-title":"Evidence and applicability of stress cardiovascular magnetic resonance in detecting coronary artery disease: state of the art","volume":"10","author":"Baritussio","year":"2021","journal-title":"J Clin Med"},{"key":"2026111312060303200_ehag678-B60","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"2026111312060303200_ehag678-B61","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1161\/CIRCIMAGING.113.000416","article-title":"Cardiac magnetic resonance assessment of myocarditis","volume":"6","author":"Friedrich","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B62","doi-asserted-by":"publisher","DOI":"10.1148\/ryct.2019190010","article-title":"Comparison of original and 2018 lake louise criteria for diagnosis of acute myocarditis: results of a validation cohort","volume":"1","author":"Luetkens","year":"2019","journal-title":"Radiol Cardiothorac Imaging"},{"key":"2026111312060303200_ehag678-B63","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.120.007405","article-title":"Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document","volume":"13","author":"Ammirati","year":"2020","journal-title":"Circ Heart Fail"},{"key":"2026111312060303200_ehag678-B64","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.jcmg.2021.11.017","article-title":"Multiparametric cardiovascular magnetic resonance approach in diagnosing, monitoring, and prognostication of myocarditis","volume":"15","author":"Eichhorn","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B65","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1007\/s10554-023-02927-6","article-title":"Cardiovascular magnetic resonance (CMR) and positron emission tomography (PET) imaging in the diagnosis and follow-up of patients with acute myocarditis and chronic inflammatory cardiomyopathy: a review paper with practical recommendations on behalf of the European Society of Cardiovascular Radiology (ESCR)","volume":"39","author":"Caobelli","year":"2023","journal-title":"Int J Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B66","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.116.005242","article-title":"Detection and monitoring of acute myocarditis applying quantitative cardiovascular magnetic resonance","volume":"10","author":"von Knobelsdorff-Brenkenhoff","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B67","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jcmg.2011.11.022","article-title":"Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis","volume":"5","author":"Lurz","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B68","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.jacc.2009.02.007","article-title":"Cardiovascular magnetic resonance in myocarditis: a JACC white paper","volume":"53","author":"Friedrich","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026111312060303200_ehag678-B69","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10554-017-1063-9","article-title":"Clinical applications of multi-parametric CMR in myocarditis and systemic inflammatory diseases","volume":"34","author":"Lagan","year":"2018","journal-title":"Int J Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B70","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1532-429X-16-36","article-title":"Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents","volume":"16","author":"Ferreira","year":"2014","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026111312060303200_ehag678-B71","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1016\/j.jacc.2016.02.013","article-title":"Comprehensive cardiac magnetic resonance imaging in patients with suspected myocarditis: the MyoRacer-trial","volume":"67","author":"Lurz","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026111312060303200_ehag678-B72","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1016\/j.jacc.2019.08.1061","article-title":"Prognostic value of repeating cardiac magnetic resonance in patients with acute myocarditis","volume":"74","author":"Aquaro","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026111312060303200_ehag678-B73","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.015351","article-title":"Predictors of mortality in patients with biopsy-proven viral myocarditis: 10-year outcome data","volume":"9","author":"Greulich","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2026111312060303200_ehag678-B74","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","article-title":"Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations","volume":"72","author":"Ferreira","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026111312060303200_ehag678-B75","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/eurheartj\/ehy730","article-title":"Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC)","volume":"40","author":"Pelliccia","year":"2019","journal-title":"Eur Heart J"},{"key":"2026111312060303200_ehag678-B76","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1161\/CIRCULATIONAHA.121.058457","article-title":"Genetic architecture of acute myocarditis and the overlap with inherited cardiomyopathy","volume":"146","author":"Lota","year":"2022","journal-title":"Circulation"},{"key":"2026111312060303200_ehag678-B77","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1136\/heartjnl-2012-303418","article-title":"Increased left ventricular trabeculation in highly trained athletes: do we need more stringent criteria for the diagnosis of left ventricular non-compaction in athletes?","volume":"99","author":"Gati","year":"2013","journal-title":"Heart"},{"key":"2026111312060303200_ehag678-B78","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1161\/CIRCULATIONAHA.114.008554","article-title":"Reversible de novo left ventricular trabeculations in pregnant women: implications for the diagnosis of left ventricular noncompaction in low-risk populations","volume":"130","author":"Gati","year":"2014","journal-title":"Circulation"},{"key":"2026111312060303200_ehag678-B79","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/j.jacc.2006.07.049","article-title":"Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy","volume":"48","author":"Assomull","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026111312060303200_ehag678-B80","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1001\/jama.2013.1363","article-title":"Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy","volume":"309","author":"Gulati","year":"2013","journal-title":"JAMA"},{"key":"2026111312060303200_ehag678-B81","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.jcmg.2018.03.006","article-title":"The prognostic value of late gadolinium-enhanced cardiac magnetic resonance imaging in nonischemic dilated cardiomyopathy: a review and meta-analysis","volume":"11","author":"Becker","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B82","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.jcmg.2020.11.006","article-title":"Progression of myocardial fibrosis in nonischemic DCM and association with mortality and heart failure outcomes","volume":"14","author":"Mandawat","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B83","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jchf.2016.09.017","article-title":"Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis","volume":"5","author":"Di Marco","year":"2017","journal-title":"JACC Heart Fail"},{"key":"2026111312060303200_ehag678-B84","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ejhf.2333","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"24","author":"Authors\/Task Force Members","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026111312060303200_ehag678-B85","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12968-014-0081-1","article-title":"Left ventricular systolic function and the pattern of late-gadolinium-enhancement independently and additively predict adverse cardiac events in muscular dystrophy patients","volume":"16","author":"Florian","year":"2014","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026111312060303200_ehag678-B86","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Authors\/Task Force Members","year":"2014","journal-title":"Eur Heart J"},{"key":"2026111312060303200_ehag678-B87","doi-asserted-by":"publisher","first-page":"e558","DOI":"10.1161\/CIR.0000000000000937","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical practice guidelines","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"key":"2026111312060303200_ehag678-B88","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.jcmg.2017.08.005","article-title":"Role of cardiac magnetic resonance in the diagnosis and prognosis of nonischemic cardiomyopathy","volume":"10","author":"Patel","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B89","doi-asserted-by":"publisher","first-page":"E118","DOI":"10.1093\/eurheartj\/suab105","article-title":"Risk stratification in cardiomyopathies (dilated, hypertrophic, and arrhythmogenic cardiomyopathy) by cardiac magnetic resonance imaging","volume":"23","author":"Guglielmo","year":"2021","journal-title":"Eur Heart J Suppl"},{"key":"2026111312060303200_ehag678-B90","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.amjcard.2016.11.010","article-title":"Comparison of maximal wall thickness in hypertrophic cardiomyopathy differs between magnetic resonance imaging and transthoracic echocardiography","volume":"119","author":"Bois","year":"2017","journal-title":"Am J Cardiol"},{"key":"2026111312060303200_ehag678-B91","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.amjcard.2023.11.003","article-title":"Prognostic role of the progression of late gadolinium enhancement in hypertrophic cardiomyopathy","volume":"211","author":"Aquaro","year":"2024","journal-title":"Am J Cardiol"},{"key":"2026111312060303200_ehag678-B92","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"key":"2026111312060303200_ehag678-B93","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.echo.2021.07.015","article-title":"Left ventricular apical aneurysms in hypertrophic cardiomyopathy: equivalent detection by magnetic resonance imaging and contrast echocardiography","volume":"34","author":"Lee","year":"2021","journal-title":"J Am Soc Echocardiogr"},{"key":"2026111312060303200_ehag678-B94","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.jcmg.2022.03.029","article-title":"Clinical characteristics and prognostic importance of left ventricular apical aneurysms in hypertrophic cardiomyopathy","volume":"15","author":"Lee","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B95","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ejhf.2140","article-title":"Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology working group on myocardial and pericardial diseases","volume":"23","author":"Garcia-Pavia","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026111312060303200_ehag678-B96","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12968-017-0419-6","article-title":"The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis","volume":"20","author":"Lin","year":"2018","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026111312060303200_ehag678-B97","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s00392-022-02005-2","article-title":"Native T1 mapping for the diagnosis of cardiac amyloidosis in patients with left ventricular hypertrophy","volume":"112","author":"Lavall","year":"2023","journal-title":"Clin Res Cardiol"},{"key":"2026111312060303200_ehag678-B98","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3390\/jcm11030651","article-title":"Magnetic resonance for differential diagnosis of left ventricular hypertrophy: diagnostic and prognostic implications","volume":"11","author":"Aquaro","year":"2022","journal-title":"J Clin Med"},{"key":"2026111312060303200_ehag678-B99","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/13506129.2022.2064739","article-title":"Prevalence and diagnostic value of extra-left ventricle echocardiographic findings in transthyretin-related cardiac amyloidosis","volume":"29","author":"Di Bella","year":"2022","journal-title":"Amyloid"},{"key":"2026111312060303200_ehag678-B100","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.121.012506","article-title":"Cardiac magnetic resonance-derived extracellular volume mapping for the quantification of hepatic and splenic amyloid","volume":"14","author":"Chacko","year":"2021","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B101","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis","volume":"132","author":"Fontana","year":"2015","journal-title":"Circulation"},{"key":"2026111312060303200_ehag678-B102","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.jcmg.2020.03.010","article-title":"Native T1 mapping, extracellular volume mapping, and late gadolinium enhancement in cardiac amyloidosis: a meta-analysis","volume":"13","author":"Pan","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B103","doi-asserted-by":"publisher","first-page":"4722","DOI":"10.1093\/eurheartj\/ehac363","article-title":"Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment","volume":"43","author":"Martinez-Naharro","year":"2022","journal-title":"Eur Heart J"},{"key":"2026111312060303200_ehag678-B104","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12968-022-00866-0","article-title":"T2 mapping in myocardial disease: a comprehensive review","volume":"24","author":"O'Brien","year":"2022","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026111312060303200_ehag678-B105","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1016\/j.jacc.2018.03.536","article-title":"Myocardial edema and prognosis in amyloidosis","volume":"71","author":"Kotecha","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026111312060303200_ehag678-B106","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.jcmg.2019.07.015","article-title":"How to image cardiac amyloidosis: a practical approach","volume":"13","author":"Dorbala","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B107","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/j.jcmg.2018.03.020","article-title":"Proposed stages of myocardial phenotype development in fabry disease","volume":"12","author":"Nordin","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B108","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.jcmg.2018.11.039","article-title":"The role of cardiac imaging in the diagnosis and management of Anderson-Fabry Disease","volume":"12","author":"Perry","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B109","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1136\/hrt.2008.162800","article-title":"Effects of enzyme-replacement therapy in patients with Anderson-Fabry disease: a prospective long-term cardiac magnetic resonance imaging study","volume":"95","author":"Imbriaco","year":"2009","journal-title":"Heart"},{"key":"2026111312060303200_ehag678-B110","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jacc.2022.06.022","article-title":"Validated model for prediction of adverse cardiac outcome in patients with fabry disease","volume":"80","author":"Orsborne","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026111312060303200_ehag678-B111","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1093\/eurheartj\/ehae356","article-title":"Management of cardiac sarcoidosis","volume":"45","author":"Sharma","year":"2024","journal-title":"Eur Heart J"},{"key":"2026111312060303200_ehag678-B112","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1161\/CIRCEP.113.000932","article-title":"Arrhythmogenic right ventricular dysplasia\/cardiomyopathy and cardiac sarcoidosis: distinguishing features when the diagnosis is unclear","volume":"7","author":"Philips","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026111312060303200_ehag678-B113","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1093\/eurheartj\/ehad067","article-title":"Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis","volume":"44","author":"Lehtonen","year":"2023","journal-title":"Eur Heart J"},{"key":"2026111312060303200_ehag678-B114","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"2026111312060303200_ehag678-B115","doi-asserted-by":"publisher","first-page":"121","DOI":"10.17996\/anc.17-00029","article-title":"Japanese guidelines for cardiac sarcoidosis","volume":"3","author":"Yoshinaga","year":"2017","journal-title":"Ann Nucl Cardiol"},{"key":"2026111312060303200_ehag678-B116","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.jacc.2018.01.016","article-title":"Spectrum of restrictive and infiltrative cardiomyopathies: part 1 of a 2-part series","volume":"71","author":"Pereira","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026111312060303200_ehag678-B117","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.jacc.2018.01.017","article-title":"Spectrum of restrictive and infiltrative cardiomyopathies: part 2 of a 2-part series","volume":"71","author":"Pereira","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026111312060303200_ehag678-B118","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1093\/ehjci\/jex034","article-title":"Multimodality imaging in restrictive cardiomyopathies: an EACVI expert consensus document in collaboration with the \u201cworking group on myocardial and pericardial diseases\u201d of the European Society of Cardiology endorsed by the Indian academy of echocardiography","volume":"18","author":"Habib","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B119","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","article-title":"Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone","volume":"88","author":"Yazaki","year":"2001","journal-title":"Am J Cardiol"},{"key":"2026111312060303200_ehag678-B120","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.032047","article-title":"Relationship of mild to moderate impairment of left ventricular ejection fraction with fatal ventricular arrhythmic events in cardiac sarcoidosis","volume":"13","author":"Akama","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"2026111312060303200_ehag678-B121","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"key":"2026111312060303200_ehag678-B122","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s41824-021-00119-w","article-title":"Combined simultaneous FDG-PET\/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis","volume":"5","author":"Cheung","year":"2021","journal-title":"Eur J Hybrid Imaging"},{"key":"2026111312060303200_ehag678-B123","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/eurheartj\/ehq025","article-title":"Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: proposed modification of the task force criteria","volume":"31","author":"Marcus","year":"2010","journal-title":"Eur Heart J"},{"key":"2026111312060303200_ehag678-B124","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/ehjci\/jew229","article-title":"Comprehensive multi-modality imaging approach in arrhythmogenic cardiomyopathy-an expert consensus document of the European Association of Cardiovascular Imaging","volume":"18","author":"Haugaa","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B125","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ijcard.2020.06.005","article-title":"Diagnosis of arrhythmogenic cardiomyopathy: the Padua criteria","volume":"319","author":"Corrado","year":"2020","journal-title":"Int J Cardiol"},{"key":"2026111312060303200_ehag678-B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2023.131447","article-title":"Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European task force consensus report","volume":"395","author":"Corrado","year":"2024","journal-title":"Int J Cardiol"},{"key":"2026111312060303200_ehag678-B127","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1136\/hrt.71.3.215","article-title":"Diagnosis of arrhythmogenic right ventricular dysplasia\/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology","volume":"71","author":"McKenna","year":"1994","journal-title":"Br Heart J"},{"key":"2026111312060303200_ehag678-B128","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.1016\/j.ijcard.2013.04.208","article-title":"Prognostic value of cardiovascular magnetic resonance in patients with suspected arrhythmogenic right ventricular cardiomyopathy","volume":"168","author":"Deac","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026111312060303200_ehag678-B129","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehv162","article-title":"Treatment of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: an international task force consensus statement","volume":"36","author":"Corrado","year":"2015","journal-title":"Eur Heart J"},{"key":"2026111312060303200_ehag678-B130","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/j.amjcard.2018.08.007","article-title":"Prognostic role of cardiac magnetic resonance in arrhythmogenic right ventricular cardiomyopathy","volume":"122","author":"Aquaro","year":"2018","journal-title":"Am J Cardiol"},{"key":"2026111312060303200_ehag678-B131","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1161\/CIR.0b013e31829b2be6","article-title":"Cardiovascular function and treatment in beta-thalassemia major: a consensus statement from the American Heart Association","volume":"128","author":"Pennell","year":"2013","journal-title":"Circulation"},{"key":"2026111312060303200_ehag678-B132","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12968-021-00827-z","article-title":"Society for Cardiovascular Magnetic Resonance (SCMR) guidelines for reporting cardiovascular magnetic resonance examinations","volume":"24","author":"Hundley","year":"2022","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026111312060303200_ehag678-B133","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1532-429X-10-42","article-title":"Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance","volume":"10","author":"Modell","year":"2008","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026111312060303200_ehag678-B134","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1161\/CIRCULATIONAHA.109.874487","article-title":"Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major","volume":"120","author":"Kirk","year":"2009","journal-title":"Circulation"},{"key":"2026111312060303200_ehag678-B135","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/bjh.17839","article-title":"Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias","volume":"196","author":"Shah","year":"2022","journal-title":"Br J Haematol"},{"key":"2026111312060303200_ehag678-B136","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1053\/euhj.2001.2822","article-title":"Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload","volume":"22","author":"Anderson","year":"2001","journal-title":"Eur Heart J"},{"key":"2026111312060303200_ehag678-B137","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.110.007641","article-title":"On T2* magnetic resonance and cardiac iron","volume":"123","author":"Carpenter","year":"2011","journal-title":"Circulation"},{"key":"2026111312060303200_ehag678-B138","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1136\/hrt.2008.156497","article-title":"Myocardial scarring by delayed enhancement cardiovascular magnetic resonance in thalassaemia major","volume":"95","author":"Pepe","year":"2009","journal-title":"Heart"},{"key":"2026111312060303200_ehag678-B139","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12968-021-00765-w","article-title":"Myocardial iron overload by cardiovascular magnetic resonance native segmental T1 mapping: a sensitive approach that correlates with cardiac complications","volume":"23","author":"Meloni","year":"2021","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026111312060303200_ehag678-B140","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.111.050773","article-title":"Iron overload cardiomyopathy in clinical practice","volume":"124","author":"Kremastinos","year":"2011","journal-title":"Circulation"},{"key":"2026111312060303200_ehag678-B141","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1093\/ehjci\/jeab253","article-title":"Multi-modality imaging assessment of native valvular regurgitation: an EACVI and ESC council of valvular heart disease position paper","volume":"23","author":"Lancellotti","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B142","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1093\/eurheartj\/ehaf194","article-title":"2025 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"46","author":"Praz","year":"2025","journal-title":"Eur Heart J"},{"key":"2026111312060303200_ehag678-B143","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.jcmg.2018.08.036","article-title":"Diagnostic and prognostic utility of cardiac magnetic resonance imaging in aortic regurgitation","volume":"12","author":"Kammerlander","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B144","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1080\/10976640600604856","article-title":"Severity of mitral and aortic regurgitation as assessed by cardiovascular magnetic resonance: optimizing correlation with Doppler echocardiography","volume":"8","author":"Gelfand","year":"2006","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026111312060303200_ehag678-B145","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.amjcard.2011.05.034","article-title":"Comparison of severity of aortic regurgitation by cardiovascular magnetic resonance versus transthoracic echocardiography","volume":"108","author":"Gabriel","year":"2011","journal-title":"Am J Cardiol"},{"key":"2026111312060303200_ehag678-B146","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/j.jacc.2023.03.001","article-title":"Influence of cardiac remodeling on clinical outcomes in patients with aortic regurgitation","volume":"81","author":"Malahfji","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026111312060303200_ehag678-B147","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1161\/CIRCULATIONAHA.111.083600","article-title":"Aortic regurgitation quantification using cardiovascular magnetic resonance: association with clinical outcome","volume":"126","author":"Myerson","year":"2012","journal-title":"Circulation"},{"key":"2026111312060303200_ehag678-B148","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1148\/rg.2019180091","article-title":"Four-dimensional flow MRI: principles and cardiovascular applications","volume":"39","author":"Azarine","year":"2019","journal-title":"Radiographics"},{"key":"2026111312060303200_ehag678-B149","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jcmg.2019.03.029","article-title":"The prognostic role of late gadolinium enhancement in aortic stenosis: a systematic review and meta-analysis","volume":"13","author":"Papanastasiou","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B150","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1001\/jama.2024.22730","article-title":"Early intervention in patients with asymptomatic severe aortic stenosis and myocardial fibrosis: the EVOLVED randomized clinical trial","volume":"333","author":"Loganath","year":"2025","journal-title":"JAMA"},{"key":"2026111312060303200_ehag678-B151","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.echo.2017.01.007","article-title":"Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance","volume":"30","author":"Zoghbi","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"key":"2026111312060303200_ehag678-B152","doi-asserted-by":"publisher","first-page":"342","DOI":"10.21037\/qims.2018.04.01","article-title":"Multimodality imaging for the quantitative assessment of mitral regurgitation","volume":"8","author":"Chew","year":"2018","journal-title":"Quant Imaging Med Surg"},{"key":"2026111312060303200_ehag678-B153","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1161\/CIRCULATIONAHA.115.017888","article-title":"Determination of clinical outcome in mitral regurgitation with cardiovascular magnetic resonance quantification","volume":"133","author":"Myerson","year":"2016","journal-title":"Circulation"},{"key":"2026111312060303200_ehag678-B154","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1161\/CIRCULATIONAHA.120.050214","article-title":"Replacement myocardial fibrosis in patients with mitral valve prolapse: relation to mitral regurgitation, ventricular remodeling, and arrhythmia","volume":"143","author":"Constant Dit Beaufils","year":"2021","journal-title":"Circulation"},{"key":"2026111312060303200_ehag678-B155","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1093\/europace\/euac125","article-title":"EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on valvular heart disease and the European Association of Cardiovascular Imaging endorsed cby the Heart Rhythm Society, by the Asia Pacific Heart Rhythm Society, and by the Latin American Heart Rhythm Society","volume":"24","author":"Sabbag","year":"2022","journal-title":"Europace"},{"key":"2026111312060303200_ehag678-B156","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/j.jcmg.2022.08.002","article-title":"Mitral annular disjunction: normal or abnormal: it is all about location","volume":"15","author":"Haugaa","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B157","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.025364","article-title":"Prevalence of mitral Annulus disjunction and mitral valve prolapse in patients with idiopathic ventricular fibrillation","volume":"11","author":"Groeneveld","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2026111312060303200_ehag678-B158","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.jcmg.2020.10.027","article-title":"Importance of myocardial fibrosis in functional mitral regurgitation: from outcomes to decision-making","volume":"14","author":"Lopes","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B159","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1007\/s00330-020-07140-w","article-title":"T1 mapping and cardiac magnetic resonance feature tracking in mitral valve prolapse","volume":"31","author":"Guglielmo","year":"2021","journal-title":"Eur Radiol"},{"key":"2026111312060303200_ehag678-B160","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12968-021-00797-2","article-title":"Myocardial extracellular volume by T1 mapping: a new marker of arrhythmia in mitral valve prolapse","volume":"23","author":"Pavon","year":"2021","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026111312060303200_ehag678-B161","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.119.010356","article-title":"Usefulness of cardiac magnetic resonance imaging in aortic stenosis","volume":"13","author":"Bohbot","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B162","doi-asserted-by":"publisher","DOI":"10.1186\/1532-429X-14-82","article-title":"CMR in inflammatory vasculitis","volume":"14","author":"Raman","year":"2012","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026111312060303200_ehag678-B163","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.118.008471","article-title":"Detection of inflammatory aortopathies using multimodality imaging","volume":"12","author":"Bois","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B164","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.echo.2014.11.015","article-title":"Multimodality imaging of diseases of the thoracic aorta in adults: from the American Society of Echocardiography and the European Association of Cardiovascular Imaging: endorsed by the Society of Cardiovascular Computed Tomography and Society for Cardiovascular Magnetic Resonance","volume":"28","author":"Goldstein","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"2026111312060303200_ehag678-B165","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/jmri.21256","article-title":"Non-contrast-enhanced MR angiography of the thoracic aorta using cardiac and navigator-gated magnetization-prepared three-dimensional steady-state free precession","volume":"27","author":"Amano","year":"2008","journal-title":"J Magn Reson Imaging"},{"key":"2026111312060303200_ehag678-B166","doi-asserted-by":"publisher","first-page":"902","DOI":"10.2214\/AJR.07.2997","article-title":"Unenhanced MR angiography of the thoracic aorta: initial clinical evaluation","volume":"190","author":"Francois","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"2026111312060303200_ehag678-B167","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jcmg.2021.09.023","article-title":"Wall shear stress predicts aortic dilation in patients with bicuspid aortic valve","volume":"15","author":"Guala","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B168","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12968-022-00852-6","article-title":"False lumen rotational flow and aortic stiffness are associated with aortic growth rate in patients with chronic aortic dissection of the descending aorta: a 4D flow cardiovascular magnetic resonance study","volume":"24","author":"Ruiz-Munoz","year":"2022","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026111312060303200_ehag678-B169","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12968-023-00942-z","article-title":"4D flow cardiovascular magnetic resonance consensus statement: 2023 update","volume":"25","author":"Bissell","year":"2023","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026111312060303200_ehag678-B170","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12968-018-0451-1","article-title":"Aortic flow patterns and wall shear stress maps by 4D-flow cardiovascular magnetic resonance in the assessment of aortic dilatation in bicuspid aortic valve disease","volume":"20","author":"Rodriguez-Palomares","year":"2018","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026111312060303200_ehag678-B171","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","article-title":"2024 ESC guidelines for the management of peripheral arterial and aortic diseases","volume":"45","author":"Mazzolai","year":"2024","journal-title":"Eur Heart J"},{"key":"2026111312060303200_ehag678-B172","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1093\/eurheartj\/ehu281","article-title":"2014 ESC guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The task force for the diagnosis and treatment of aortic diseases of the European Society of Cardiology (ESC)","volume":"35","author":"Erbel","year":"2014","journal-title":"Eur Heart J"},{"key":"2026111312060303200_ehag678-B173","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1161\/CIRCULATIONAHA.106.685487","article-title":"Aortic dilatation and dissection in turner syndrome","volume":"116","author":"Matura","year":"2007","journal-title":"Circulation"},{"key":"2026111312060303200_ehag678-B174","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.echo.2016.04.006","article-title":"Multimodality assessment of ascending aortic diameters: comparison of different measurement methods","volume":"29","author":"Rodriguez-Palomares","year":"2016","journal-title":"J Am Soc Echocardiogr"},{"key":"2026111312060303200_ehag678-B175","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1161\/CIRCIMAGING.108.768911","article-title":"Aortic root measurement by cardiovascular magnetic resonance: specification of planes and lines of measurement and corresponding normal values","volume":"1","author":"Burman","year":"2008","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B176","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.echo.2018.08.004","article-title":"Implications of asymmetry and valvular morphotype on echocardiographic measurements of the aortic root in bicuspid aortic valve","volume":"32","author":"Vis","year":"2019","journal-title":"J Am Soc Echocardiogr"},{"key":"2026111312060303200_ehag678-B177","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1016\/j.jacc.2022.04.017","article-title":"False lumen flow assessment by magnetic resonance imaging and long-term outcomes in uncomplicated aortic dissection","volume":"79","author":"Evangelista","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026111312060303200_ehag678-B178","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1161\/CIR.0000000000001106","article-title":"2022 ACC\/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical practice guidelines","volume":"146","author":"Isselbacher","year":"2022","journal-title":"Circulation"},{"key":"2026111312060303200_ehag678-B179","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1161\/CIRCIMAGING.113.000553","article-title":"Is MRI the preferred method for evaluating right ventricular size and function in patients with congenital heart disease? : MRI is the preferred method for evaluating right ventricular size and function in patients with congenital heart disease","volume":"7","author":"Geva","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B180","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1161\/CIRCIMAGING.113.000932","article-title":"Sample size and cost analysis for pulmonary arterial hypertension drug trials using various imaging modalities to assess right ventricular size and function end points","volume":"7","author":"Addetia","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B181","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/eurheartj\/ehaa554","article-title":"2020 ESC guidelines for the management of adult congenital heart disease","volume":"42","author":"Baumgartner","year":"2021","journal-title":"Eur Heart J"},{"key":"2026111312060303200_ehag678-B182","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1148\/radiology.185.3.1438767","article-title":"Arterial and venous blood flow: noninvasive quantitation with MR imaging","volume":"185","author":"Pelc","year":"1992","journal-title":"Radiology"},{"key":"2026111312060303200_ehag678-B183","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1002\/nbm.2927","article-title":"Assessment of PDA shunt and systemic blood flow in newborns using cardiac MRI","volume":"26","author":"Broadhouse","year":"2013","journal-title":"NMR Biomed"},{"key":"2026111312060303200_ehag678-B184","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ijcard.2011.12.081","article-title":"The functional right ventricle and tricuspid regurgitation in Ebstein's anomaly","volume":"167","author":"Fratz","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026111312060303200_ehag678-B185","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/0002-9149(85)90398-4","article-title":"Magnetic resonance imaging of constrictive pericardial disease","volume":"55","author":"Soulen","year":"1985","journal-title":"Am J Cardiol"},{"key":"2026111312060303200_ehag678-B186","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1161\/CIRCULATIONAHA.111.026070","article-title":"Cardiac magnetic resonance imaging pericardial late gadolinium enhancement and elevated inflammatory markers can predict the reversibility of constrictive pericarditis after antiinflammatory medical therapy: a pilot study","volume":"124","author":"Feng","year":"2011","journal-title":"Circulation"},{"key":"2026111312060303200_ehag678-B187","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.jcmg.2016.10.020","article-title":"Quantitative pericardial delayed hyperenhancement informs clinical course in recurrent pericarditis","volume":"10","author":"Kumar","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B188","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.amjcard.2014.11.041","article-title":"Usefulness of cardiac magnetic resonance-guided management in patients with recurrent pericarditis","volume":"115","author":"Alraies","year":"2015","journal-title":"Am J Cardiol"},{"key":"2026111312060303200_ehag678-B189","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jcmg.2014.05.009","article-title":"Value of CMR for the differential diagnosis of cardiac masses","volume":"7","author":"Pazos-Lopez","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026111312060303200_ehag678-B190","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1148\/radiol.13121239","article-title":"MR imaging of cardiac tumors and masses: a review of methods and clinical applications","volume":"268","author":"Motwani","year":"2013","journal-title":"Radiology"},{"key":"2026111312060303200_ehag678-B191","doi-asserted-by":"publisher","first-page":"W842","DOI":"10.2214\/AJR.11.6903","article-title":"Cardiac masses, part 2: key imaging features for diagnosis and surgical planning","volume":"197","author":"Buckley","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"2026111312060303200_ehag678-B192","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1136\/heartjnl-2015-308495","article-title":"British Heart Rhythm S. Safe use of MRI in people with cardiac implantable electronic devices","volume":"101","author":"Lowe","year":"2015","journal-title":"Heart"},{"key":"2026111312060303200_ehag678-B193","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2021-001598","article-title":"Access to MRI for patients with cardiac pacemakers and implantable cardioverter defibrillators","volume":"8","author":"Pieri","year":"2021","journal-title":"Open Heart"},{"key":"2026111312060303200_ehag678-B194","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1007\/s00330-019-06449-5","article-title":"Making MRI available for patients with cardiac implantable electronic devices: growing need and barriers to change","volume":"30","author":"Bhuva","year":"2020","journal-title":"Eur Radiol"},{"key":"2026111312060303200_ehag678-B195","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1093\/eurheartj\/ehab350","article-title":"Evidence to support magnetic resonance conditional labelling of all pacemaker and defibrillator leads in patients with cardiac implantable electronic devices","volume":"43","author":"Bhuva","year":"2022","journal-title":"Eur Heart J"},{"key":"2026111312060303200_ehag678-B196","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1136\/heartjnl-2022-320810","article-title":"Joint British Society consensus recommendations for magnetic resonance imaging for patients with cardiac implantable electronic devices","volume":"110","author":"Bhuva","year":"2024","journal-title":"Heart"},{"key":"2026111312060303200_ehag678-B197","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1093\/eurheartj\/ehab364","article-title":"2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy","volume":"42","author":"Glikson","year":"2021","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article-pdf\/doi\/10.1093\/eurheartj\/ehag678\/71518963\/ehag678.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article-pdf\/doi\/10.1093\/eurheartj\/ehag678\/71518963\/ehag678.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:06:17Z","timestamp":1794589577000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article\/doi\/10.1093\/eurheartj\/ehag678\/8853754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":197,"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehag678","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"article-number":"ehag678"}}